Out with the old, in with the nucleus
Are you tired of binging reruns on Netflix? Maybe you need a break from reality TV but you’re not sure where to turn for high-quality entertainment? Look no further — the nucleus has it all. There’s mystery, murder, machines of extraordinary complexity and visually stunning landscapes.
Stories in nuclear signaling are unraveling at an unprecedented pace thanks to technological and conceptual advances in chemistry, biochemistry and cell biology. Our speakers will address long-standing questions about organism development, cellular identity and the genetic basis for disease.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.
You will hear about how cutting-edge interdisciplinary approaches are being used to uncover new regulatory mechanisms underlying transcription, genome structure, and other phenomena in the nucleus. We will also discuss how rapid progress in the field is inspiring new therapeutic approaches for diseases related to dysfunctional nuclear processes.
You don’t want to miss this — even the cytosol junkies will be on the edge of their seats.
Keywords: Enzyme mechanism, genetics and disease, chemical probes, transcription regulation, chromatin modifications, genome structure.
Who should attend: You. Our speakers span a wide breadth of biological phenomena, scientific disciplines and technologies. We have something for everyone. Current projections: standing room only.
Your session’s theme song: by John Williams
This song is about the most important genetics experiment ever performed.
This session is powered by “hot, nasty, bad-*ss speed.” — Eleanor Roosevelt, Talladega Nights
Signaling mechanisms in the nucleus
Chemical strategies to study nuclear processes
Chair: Aaron Johnson
Anna Mapp, University of Michigan
Glen Liszczak, University of Texas Southwestern Medical Center
Oliver Bell, University of Southern California Kerk School of Medicine
Minkui Luo, Memorial Sloan Kettering Cancer Center
Chromatin organization, replication and repair
Chair: Katharine Diehl
Aaron Streets, University of California, Berkeley
Aaron Johnson, University of Colorado Anschutz Medical Campus
Carl Wu, Johns Hopkins University
Serena Sanulli, Stanford University
Chromatin modifications in the nucleus
Chair: Glen Liszczak
Alex Ruthenberg, University of Chicago
Katharine Diehl, University of Utah
Tim Stasevich, Colorado State University
Phil Cole, Harvard University
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.